Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk
Clinical trial NCT06685289 · RECRUITING
Trial details
- NCT number
- NCT06685289
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2026-11-15
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.